Cite
Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial.
MLA
Duinkerken, Charlotte W., et al. “Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial.” Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, vol. 42, no. 5, June 2021, pp. 678–85. EBSCOhost, https://doi.org/10.1097/MAO.0000000000003069.
APA
Duinkerken, C. W., de Weger, V. A., Dreschler, W. A., van der Molen, L., Pluim, D., Rosing, H., Nuijen, B., Hauptmann, M., Beijnen, J. H., Balm, A. J. M., de Boer, J. P., Burgers, J. A., Marchetti, S., Schellens, J. H. M., & Zuur, C. L. (2021). Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42(5), 678–685. https://doi.org/10.1097/MAO.0000000000003069
Chicago
Duinkerken, Charlotte W, Vincent A de Weger, Wouter A Dreschler, Lisette van der Molen, Dick Pluim, Hilde Rosing, Bastiaan Nuijen, et al. 2021. “Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial.” Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 42 (5): 678–85. doi:10.1097/MAO.0000000000003069.